Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04885374

China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Dongzhimen Hospital, Beijing · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A multi-center registration study of clinical characteristics of amyotrophic lateral sclerosis (ALS) patients with traditional Chinese medicine (TCM).

Detailed description

The CARE-TCM is a prospective, multi-center, patient registry study. Eligible ALS patients with TCM treatments will be enrolled in the registry. After enrollment, this research collects the individual characteristics of patients' status. Longitudinal follow-up data are collected from both patients (primary caregivers) and their treating neurologists every 3 months for 5 years. The aims of the CARE-TCM are to: 1) explore the general characteristics of ALS patients with TCM and; 2) assess the effectiveness and safety of various TCMs on ALS based on nationwide registry outcome collecting process.

Conditions

Timeline

Start date
2021-03-01
Primary completion
2027-05-01
Completion
2028-03-01
First posted
2021-05-13
Last updated
2021-05-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04885374. Inclusion in this directory is not an endorsement.

China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine (NCT04885374) · Clinical Trials Directory